We came across a bullish thesis on Novo Nordisk A/S (NVO) on Substack by Felix. In this article, we will summarize the bulls’ thesis on NVO. Novo Nordisk A/S (NVO)’s share was trading at $64.49 as of ...

Girls Next Door alum Kendra Wilkinson shared that she recently tried using a weight loss drug but quickly changed her mind, ...

Skye Bioscience currently trades essentially at cash value, meaning investors who buy in today get a weight loss drug ...

In this week’s edition of InnovationRx, we look at the impact of Medicaid cuts, a $400 million obesity bet, a study of bias ...

Glycomine’s Series C raise highlights investor confidence in the company amid pressure on the paediatric rare disease sector.

The biotech is developing an experimental drug for the most common of a family of disorders all caused by errors in ...

Evotec sharpens focus on pioneering drug discovery and charts clear path toward sustainable profitable growthStrategy builds on technology and science leadership, focusing on high-growth, high-value ...

To keep you informed of recent activities, below are several of the most significant federal and state events that have influenced the ...

Hermes has leapfrogged LVMH to become the world's most valuable luxury goods firm. The French firm, famed for its silk scarves and Birkin handbags, secured the top spot yesterday (April 15) after ...

U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or ...

Hamburg, Germany, 17 April 2025: Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announced its financial results for FY 2024, provided guidance for FY ...